United States v. Kenney

550 F. Supp. 2d 118, 2008 U.S. Dist. LEXIS 35281, 2008 WL 1891469
CourtDistrict Court, D. Maine
DecidedApril 28, 2008
DocketCR-07-66-B-W
StatusPublished
Cited by2 cases

This text of 550 F. Supp. 2d 118 (United States v. Kenney) is published on Counsel Stack Legal Research, covering District Court, D. Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Kenney, 550 F. Supp. 2d 118, 2008 U.S. Dist. LEXIS 35281, 2008 WL 1891469 (D. Me. 2008).

Opinion

ORDER ON MOTION DIRECTING THE RETURN OF PHYSICAL EVIDENCE

JOHN A. WOODCOCK, JR., District Judge.

Over the Defendant’s objection and acting pursuant to the All Writs Act, the Court orders the Defendant to return' a sample of blood to the Government to allow scientific testing of its contents.

I. STATEMENT OF FACTS

A. The Indictment

On September 24, 2007, Rochelle Ken-ney was indicted for supplying her late brother, John Kenney, with methadone and causing his death. Indictment (Docket # 1). Specifically, the Indictment charges that Ms. Kenney engaged in a scheme to report misinformation to her substance abuse treatment provider and others in order to obtain doses of methadone, clonazepam, and diazepam, some of which she then diverted to her brother. The Indictment alleges that John Kenney *119 died on April 26, 2005 as a result of his use of the methadone Ms. Kenney supplied. The Indictment contains three counts: (1) Count I — Health Care Fraud — an alleged violation of 18 U.S.C. § 1347; (2) Count II — Unlawful Distribution (Methadone)— an alleged violation of 18 U.S.C. § 841(a)(1); and, (3) Count III — Unlawful Distribution (Diazepam) — an alleged violation of 18 U.S.C. § 841(a)(1). In addition, Counts One and Two allege that the enhanced penalty provisions of sections 1347 and 841(b)(1)(C) apply to the charged crimes. 1

To prove Count One, the Government must demonstrate that Ms. Kenney knowingly and willfully executed a scheme or artifice to defraud a health care benefit program and to obtain by false or fraudulent pretenses the delivery of or payment for health care benefits or services. To prove Counts Two and Three, the Government must demonstrate that Ms. Kenney knowingly or intentionally possessed these controlled substances with the intent to distribute them. To establish the enhanced penalties for Counts One and Two, the Government must prove that Mr. Ken-ney died as a consequence of his ingestion of these controlled substances.

B.Why John Kenney Died

Why John Kenney died on April 26, 2005, has become a central focus of the Government’s case and Ms. Kenney’s defense. The answer to this critical question, however, has become immeasurably complicated by the failure of the Government’s laboratory, Central Valley Toxicology (CVT) of Clovis, California, to follow standard scientific procedure. Upon Mr. Kenney’s death, a physician from the Maine Medical Examiner’s Office drew a sample of his blood and sent the sample to CVT; CVT conducted a toxicology test of the blood sample. Based on CVT’s results, the state medical officer concluded that Mr. Kenney has died of acute methadone and diazepam toxicity. This conclusion led to Ms. Kenney’s indictment.

C. A Botched Test

After Ms. Kenney was indicted, defense counsel requested that the Government provide a sample of Mr. Kenney’s blood so that it could be retested. The Government discovered that the state of Maine had destroyed its sample, but CVT still had its sample. On December 21, 2007, defense counsel asked that 6-8 ml of Mr. Kenney’s blood be sent from CVT to NMS Labs in Willow Grove, Pennsylvania. The Government forwarded the request to CVT and asked it to comply.

On January 15, 2008, the Government received a letter from Bill Posey, the CVT Director, confirming that CVT had failed to follow standard laboratory procedure in testing Mr. Kenney’s blood and that he had to recant his original opinions. Mr. Posey said he could not retest the blood sample because the entire sample — approximately 9 ml — had been sent to NMS at the Government’s direction. The Government retained a new laboratory, AIT Labs, and asked defense counsel to send the sample to A IT for testing.

D. A Question of Quantity

Defense counsel balked and the Government moved under the Al 1 Writs Act for an order requiring the Defendant to return the blood sample. Government’s Mot. for Order Directing the Return of Physical *120 Evidence (Docket #56) (Govt’s Mot.). The dispute centers on the amount of blood necessary to perform adequate toxicology tests. Ms. Kenney supplied an affidavit from Dr. Laura Labay, a forensic toxicologist from NMS, in which Ms. La-bay stated that on January 4, 2008, NMS received 7.8 ml of blood from CVT. Dr. Labay initially understood that the entire sample would be available for testing and she directed that the laboratory commence drug-specific testing. On or about January 18, 2008, she received word that quality control issues had been discovered at CVT and, at that point, NMS stopped all testing. As of January 18, 2008, approximately 5.5 ml of blood remained in NMS custody. Dr. Labay has stated that she planned to use an additional 4.1 ml of blood to test for clonazepam, benzodiaze-pine, and cocaine, based on the minimum volumes necessary to obtain scientifically reliable test results.

Presumably on the assumption that the CVT test results were scientifically valid, NMS had focused its testing on the presence of other drugs. With the news that the CVT testing may have been compromised, however, N MS plans to perform a comprehensive drug screening test. It is unlikely that the amount of blood that remains — 5.5 ml — would be sufficient to conduct a comprehensive drug screen and leave enough volume for confirmation testing of clonazepam, benzodiazepine, and cocaine. Further, AIT, the Government’s new laboratory, has requested a sample of 5.0 ml. If NMS were to turn over 5.0 ml, this would leave only 0.5 ml, a volume inadequate for independent testing. In sum, in response to the Government’s request, the Defendant argues that “fundamental fairness and due process require that [she] be given sufficient access to test existing evidence so as to fully investigate her defense.” Def.’s Resp. to Government’s Mot. at 6-7 (Docket # 76).

The Government responds that the defense’s argument misses the essential point that the burden to prove that Mr. Kenney’s death resulted from methadone or other drugs rests solely with the Government. In other words, if the Government cannot gain access to the blood, there will be no need for the defense to retest the sample. The Government also points out that its laboratory is able to perform a comprehensive test with only 3.0 ml.

II. DISCUSSION

A. All Writs Act

The Government’s motion is a request that the Court, under the authority of the All Writs Act, order the Defendant to return the remaining sample of John Kenney’s blood to the Government. The All Writs Act provides: “The Supreme Court and all courts established by Act of Congress may issue all writs necessary or appropriate in aid of their respective jurisdictions and agreeable to the usages and principles of law.” 28 U.S.C. §

Related

Cite This Page — Counsel Stack

Bluebook (online)
550 F. Supp. 2d 118, 2008 U.S. Dist. LEXIS 35281, 2008 WL 1891469, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-kenney-med-2008.